• Late-Breaking Poster Abstract submission period closed on 4 August 2014. Notifications for those submissions were emailed to all authors on 19 August 2014. Late-breaking abstracts were eligible for poster presentation only and will not be included in the conference supplement published in the Journal of Cancer Education. These abstracts will be included with attendee conference materials.

    Regular abstract submission closed on 6 May 2014. Acceptance notifications for those submissions were emailed to all authors on 30 May 2014. Contact info@attendicec.org if you have not received your notification.

    About the Abstract Submissions

    The 2014 International Cancer Education Conference, organized by AACE, CPEN and EACE, accepted abstracts that emphasize cancer education curricula, programs and/or initiatives across the cancer continuum, such as:

    • Prevention, including risk factor reduction
    • Early Detection, including screening strategies
    • Treatment, including chemotherapy, immunotherapy, radiotherapy, surgery, complementary and integrative medicine
    • Survivorship, including patient and provider education and how these change over time
    • Palliative Care and End-of-Life Care, including pain and other symptom control and effective communication strategies


    Abstracts were encouraged to relate to the conference theme, Building Global Bridges, Providing Quality Cancer Education. Focal areas for abstract submission include:

    • Global Cancer Education: Share effective cancer education approaches from throughout the world, as well as opportunities for international collaboration.
    • Integrating Technologies and Multimedia into Cancer Education: Showcase developing, implementing, and evaluating creative and innovative multimedia resources.
    • Health Literacy/Communication across the Cancer Spectrum: Highlight culturally- and linguistically-appropriate pathways for effective cancer communication.
    • Special Populations: Best practices in pediatric, adolescent, and young adult cancer education for patients/families and providers. This also includes working with and for diverse populations.
    • Patient/Family Education: Program development, implementation, and evaluation: Successes, challenges, and lessons learned.
    • Healthcare Professional Education: Including medical, nursing, pharmacy, social work, etc., trainees with an additional emphasis on supporting student development.


    Abstracts were submitted in one of two categories:

    • Research in Cancer Education, including research conducted in the field of cancer education.
    • Innovations in Cancer Education, including projects or programs developed to meet a specific need in cancer education at any point throughout the cancer continuum.


    Authors were asked to read the Author Instructions, including the review criteria, before making submissions. If authors submitted an abstract in the Innovations in Cancer Education category, they were asked to read the specific Innovations Abstract Criteria.

    As a requirement for providing ANCC continuing education credits for nurses for all sessions, all abstracts will be reviewed by a nurse reviewer answering the following questions:

    • Is this activity fair balanced and free of commercial bias? (and if not, why not)
    • Is the educational content based on valid, accurate and reliable information? (and if not, recommendations for content changes)
    • Are the patient treatment recommendations included in this CE activity appropriate? (and if not, recommendations for content changes)
    • Are there important patient care guidelines for this topic that are not included in this activity? (and if so, list the guidelines)
    • Does the program address the identified learning gap(s)?
    • Will educational objectives of this activity be met and are the objectives linked to the gap(s)? (and if not, explain)
    • Does the material presented match the scope of practice for the target audience? (and if not, explain)
    • Is the educational design appropriate to the content and target audience? (and if not, explain)
    • Should any slide or illustration be deleted?  If so, please designate which one and briefly explain why.
    • Did you find any recommendations for a medication or device that is not approved by the FDA? (and if so, explain)
    • Are there published studies for this topic that are not included in this education? (and if so, list them)
    • Are there separate objectives for each presentation?
    • Was this CNE activity structured to meet the knowledge, skills and attitudes/behaviors of nurses?
    • Are the outcomes supporting best available evidence to improve professional practice, improvement in nursing practice and/or patient outcomes?


    Download PDF